CA Stock MarketDetailed Quotes
ACOG Alpha Cognition Inc
- 0.760
- +0.040+5.56%
15min DelayMarket Closed Jul 18 15:42 ET
113.94MMarket Cap-3502P/E (TTM)
0.760High0.660Low71.19KVolume0.700Open0.720Pre Close49.34KTurnover0.99052wk High0.07%Turnover Ratio149.93MShares0.23052wk Low-0.217EPS TTM82.44MFloat Cap2.490Historical HighLossP/E (Static)108.47MShs Float0.060Historical Low-0.199EPS LYR13.89%Amplitude--Dividend TTM380.00P/B1Lot Size--Div YieldTTM
About Alpha Cognition Inc Company
Alpha Cognition Inc is a clinical stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurological diseases., such as Alzheimer's disease, and Cognitive Impairment with Mild Traumatic Brain Injury (mTBI) for which there are limited or no treatment options. The Company is focused on the development of ALPHA-1062 for the treatment of mild-to-moderate Alzheimer's disease.
Company Profile
SymbolACOG
Company NameAlpha Cognition Inc
Founded2017
MarketCNQ
Employees19
Fiscal Year Ends12-31
Addressc/o 1200 – 750 West Pender Street
CityVancouver
CountryCAN
Zip CodeV6C 2T8
Phone+1 858 344-4375
Company Executives
- Name
- Position
- Salary
- Michael McFadden
- Chief Executive Officer and Director
- --
- Lauren D’Angelo
- Chief Commercial Officer
- --
- Donald Kalkofen
- Chief Financial Officer
- --
- Dr. Cedric O'Gorman, M.D.
- Chief Medical Officer
- --
- Dr. Denis Kay
- Chief Scientific Officer
- --
- Len Mertz
- Chairman of the Board
- --
- Kenneth A. Cawkell, L.L.B.
- Corporate Secretary and Director
- --
- Phillip Mertz
- Independent Director
- --
- John Havens
- Independent Director
- --
- Rajeev Bakshi
- Independent Director
- --
Heat List
CA
Overall
Symbol
Latest Price
%Chg